A detailed history of Orion Investment CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Orion Investment CO holds 29,386 shares of REGN stock, worth $21.8 Million. This represents 12.01% of its overall portfolio holdings.

Number of Shares
29,386
Previous 29,488 0.35%
Holding current value
$21.8 Million
Previous $31 Billion 0.33%
% of portfolio
12.01%
Previous 12.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1024.09 - $1201.76 $104,457 - $122,579
-102 Reduced 0.35%
29,386 $30.9 Billion
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $26 Million - $31.6 Million
29,488 New
29,488 $31 Billion

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Orion Investment CO Portfolio

Follow Orion Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Orion Investment CO with notifications on news.